Every founder who contacts us asks the same first question: "What's your minimum order quantity?" And almost every one of them expects the answer to be 5,000 or 10,000 units. The supplement manufacturing industry has conditioned people to expect high MOQs. The reality at Anarvah is 500 units — but before you decide if that's right for you, it's worth understanding what MOQ actually means and what you're trading off at the lower end.

What is MOQ in supplement manufacturing?

MOQ stands for minimum order quantity — the fewest units a manufacturer will produce in a single production run. In supplement manufacturing, MOQ is determined by a combination of factors: the fixed cost of setting up a production batch (cleaning and calibrating equipment, sourcing raw materials in minimum viable quantities, running QC tests), and the commercial minimum below which the manufacturer does not make a viable margin.

A manufacturer quoting 10,000 units as their MOQ is not being arbitrary. At that volume, raw material purchasing is efficient, batch testing costs are amortised across enough units, and the line changeover time is commercially justified. The economics genuinely change below that threshold.

Why does the supplement industry default to high MOQs?

The typical supplement manufacturing MOQ of 5,000–10,000 units exists for three reasons.

First, raw material sourcing: Most supplement manufacturers source ingredients in multi-kilogram batches. The cost-per-gram drops sharply as order size increases. If you need 2kg of KSM-66 ashwagandha extract for 500 units, the per-gram cost is significantly higher than sourcing 20kg for 5,000 units. Manufacturers with high fixed sourcing costs pass that inefficiency on as a high MOQ.

Second, batch QC testing: Every production batch requires a Certificate of Analysis (CoA) from an independent third-party laboratory. That test costs roughly the same whether you produced 500 or 5,000 units. At 500 units, the QC cost per unit is 10x higher. Manufacturers who haven't structured their business to absorb this at low volumes simply don't offer low MOQs.

Third, line economics: Setting up a production run takes time — equipment cleaning, calibration, raw material preparation, and documentation. If a manufacturer's production line can run 5,000 units per hour, setting it up for 500 units is commercially unattractive unless the pricing reflects the setup cost.

Why low MOQ options exist — and who they're designed for

Low MOQ supplement manufacturing has emerged because a structural market problem became undeniable: most first-time brand founders cannot justify buying 10,000 units of inventory before they have made a single sale.

The direct-to-consumer supplement market has democratised brand building. A founder with a credible formulation, a well-designed label, and a targeted marketing strategy can validate demand in weeks via Amazon, a DTC store, or a pilot with a distributor. The demand validation cycle is short. But the capital cycle for traditional supplement manufacturing is long — and high MOQ requirements force founders to choose between over-investing in inventory or not launching at all.

Low MOQ manufacturing solves this by absorbing the setup inefficiency into the business model — typically through higher per-unit costs — and offering a genuinely viable path to market for a first order of 500–2,500 units.

The real tradeoff: per-unit cost vs. inventory risk

This is the part most low-MOQ discussions avoid being direct about. When you order 500 units, your per-unit manufacturing cost will be meaningfully higher than if you ordered 5,000 units — typically 30–60% higher, depending on the ingredient and format.

That difference in per-unit cost is not a flaw. It is the price of validated demand. Consider the alternative: you order 5,000 units at a lower per-unit cost, invest capital in a product that has not yet been market-tested, and discover three months later that the claim positioning doesn't convert, or that your target channel requires a different format. The "savings" from the lower per-unit cost are dwarfed by the cost of 4,500 units of dead stock.

The right framing is this: low MOQ = high per-unit cost + low inventory risk. High MOQ = low per-unit cost + high inventory risk. For a first-time brand founder with no prior sales history in a category, the low-MOQ, high-per-unit cost option is almost always the correct financial decision.

What 500-unit minimum order actually looks like in practice

At Anarvah, the Starter Kit begins at 500 units per SKU. Here is what a typical first order looks like for a founder launching an ashwagandha capsule for the US market:

  • Select one formulation from our library of 200+ validated formulations (ashwagandha 300mg KSM-66, veg caps)
  • Receive a free sample of your confirmed formulation — pay only shipping
  • Approve the sample and place a 50% deposit to start production
  • Receive a CoA from an independent lab before balance payment is due
  • Receive GMP certificate, MSDS, and Certificate of Indian Origin for US customs
  • Products shipped to your US warehouse. Total timeline: 6–8 weeks

The total investment for a first run at this scale is realistic for a pre-revenue brand. You are not committing to a year's worth of inventory. If the product sells well in weeks two and three, you can reorder. If the claim positioning needs adjustment, you can change your label on the next batch without writing off thousands of unsold units.

What low MOQ doesn't cover — and when to move up

It is important to be clear about what 500-unit minimum order manufacturing typically does not include, and when graduating to a higher tier makes commercial sense.

At 500 units, you are usually working with existing (library) formulations rather than bespoke development. Custom formulation development — where a manufacturer creates a unique blend from scratch to your brief — requires higher volumes to justify the R&D and development cost. At Anarvah, that begins at the Custom Kit tier, from 2,500 units.

Similarly, trend formats like gummies, effervescent sachets, and RTD shots involve additional tooling and batch setup costs that make them commercially unviable at very low MOQs. If your target format is gummies, expect to start at a higher minimum.

EU market entry is another consideration. EU Novel Food regulations add compliance documentation requirements that are economically better absorbed across larger batch sizes. If the EU is your primary target market from day one, starting at 2,500+ units is more practical.

The signal to move from low-MOQ to higher volume is simple: consistent reorder demand. When your first batch sells through in under 8 weeks and you find yourself placing reorders, the economics shift. The per-unit cost saving at 2,500 or 5,000 units starts to compound across every reorder cycle.

Practical advice for starting at low MOQ

Start with one SKU. The temptation to launch three or four products simultaneously is understandable — you have multiple ideas and they all seem viable. Resist it. One product tested properly gives you cleaner signal than four products tested halfheartedly. Your first order should answer a specific question: does this formulation, at this price point, in this channel, convert?

Choose the right market for validation. US and UAE are the most accessible first markets for Indian-manufactured supplements — no pre-market registration required in the US, and straightforward MoHAP registration in the UAE. UK is similarly accessible. If you are tempted to launch in the EU first, take time to read the compliance requirements before you commit.

Don't treat 500 units as the end state. Low MOQ is a starting point, not a permanent operating model. The goal of your first order is to generate sales data, customer feedback, and channel insight — not to optimise per-unit margins. Use the first batch to learn. Use everything you learn to brief the next production run smarter.